Up-regulation of activation markers on basophils in patients with papuloerythroderma by Otake, Hikari et al.
Title Up-regulation of activation markers on basophils in patientswith papuloerythroderma
Author(s)Otake, Hikari; Otsuka, Atsushi; Nonomura, Yumi; Iga,Natsuko; Kabashima, Kenji




© 2016 The Authors. All articles are licensed under a Creative





Acta Derm Venereol 96
Acta Derm Venereol 2016; 96: 410–411
© 2016 The Authors. doi: 10.2340/00015555-4545
Journal Compilation © 2016 Acta Dermato-Venereologica. ISSN 0001-5555
SHORT COMMUNICATION
Papuloerythroderma is a pruritic eruption of flat-topped 
papules in a background of erythroderma that characte-
ristically spares skin folds; so-called “deck-chair sign” 
(1). Histopathology reveals a non-specific spongiotic 
dermatitis-like pattern, such as slight epidermal hyper-
plasia with spongiosis and a primarily perivascular 
dermal infiltrate with lymphocytes, histiocytes and 
eosinophils. Peripheral eosinophilia and elevated serum 
immunoglobulin E (IgE) are detected in most cases of 
papuloerythroderma.
Recent studies have shown that basophils play some 
roles in the pathogenesis of cutaneous allergic diseases, 
where eosinophils are present, by functioning as 
initiator cells. CD63, CD69, and CD203c are basophil 
activation markers that are known to be upregulated 
by cross-linking of the FcɛRIα receptor. They may 
serve as useful activation markers in several diseases, 
including chronic urticaria and prurigo (2). A previous 
study revealed that basophil-derived interleukin (IL)-4 
promotes antigen-specific T helper (Th)2 cell diffe-
rentiation (3). However, it remains unknown whether 
basophils mediate the pathological mechanisms in 
papuloerythroderma. We report here 2 cases of papu-
loerythroderma that exhibited infiltration of basophils 
with upregulation of activation markers.
CASE REPORTS
Case 1. A 73-year-old Japanese man with no relevant personal 
history presented to our department with a 1-year history of 
pruritic eruptions over his trunk and all of his limbs. Physical 
examination revealed erythematous plaques that 
avoided the skin folds, and crusty indurated le-
sions on the abdomen (Fig. 1A). His medication 
was stopped in order to exclude drug eruption. 
Laboratory data revealed: haemoglobin 12.3 g/dl 
(normal range 10.2–14.6 g/dl); white blood cell 
count 6,500/mm3 (normal range 2,800–8,300/
mm3) (61.6% neutrophils [46–62%], 17.6% lym-
phocytes [30–40%], 6.0% monocytes [ 4–7%], 
15.2% eosinophils [3–5%] and 0.2% basophils 
[0–1%]); platelet count 214,000/mm3 (normal 
range 123,000–343,000/mm3); and immunoglobu-
lin E (IgE) 1,900 IU/ml (normal range 0–250 IU/
ml). No atypical cells were detected in peripheral 
blood. Computed tomography (CT) did not reveal 
any lymphadenopathy, splenomegaly, or visceral 
tumours. Oesophagogastroduodenoscopy and co-
lonoscopy did not reveal any malignancy. A skin 
biopsy from an eruption on the patient’s abdomen 
revealed non-specific inflammatory changes with 
a perivascular infiltration of lymphohistiocytic 
cells intermingled with eosinophils in the upper 
dermis (Fig. 1B). Based on clinical and patholo-
gical findings, his eruptions were diagnosed as 
papuloerythroderma. Treatments with narrowband 
ultraviolet B (UVB) and topical corticosteroids 
gave partial relief for the pruritus and eruptions.
Case 2. A 74-year-old Japanese man presented to 
our department with a 2-month history of pruritic 
eruptions over his trunk and all of his limbs. He had 
a history of chronic hepatitis C virus infection and 
had had an operation for gastric cancer one year 
previously. He received no medication at that time. 
Physical examination revealed erythematous pla-
ques that avoided the skin folds, and crusty indura-
ted lesions on the abdomen (Fig. 2A). Laboratory 
data showed peripheral eosinophilia: white blood 
cell count 6,600/mm3 (55.4% neutrophils, 20.7% 
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Fig. 1. (A) Papuloerythroderma with typical avoidance of abdominal skin folds. (B) 
Epidermal acanthotic hyperplasia with mild spongiosis. In the dermis, perivascular 
infiltration of lymphohistiocytic cells intermingled with eosinophils. (C) Skin lesion 
formed by the coalescence of flat-topped, red-to-brown papules showing the deck-chair 
sign. (D) Spongiosis and mild acanthosis in the epidermis together with perivascular 
infiltration of lymphohistiocytic cells intermingled with eosinophils. (Haematoxylin-
eosin stain; original magnification × 200).
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lymphocytes, 6.5% monocytes, 16.3% eosinophils and 1.1% 
basophils). No atypical cells were detected in the peripheral 
blood. CT did not show any lymphadenopathy, splenomegaly, 
or visceral tumours. There was no recurrence of gastric can-
cer. A skin biopsy from an eruption on the patient’s abdomen 
revealed a perivascular infiltration of lymphohistiocytic cells 
and eosinophils in the upper dermis (Fig. 2B). Based on these 
findings, his eruptions were diagnosed as papuloerythroderma. 
Treatments with narrowband UVB, topical corticosteroids and 
topical tacrolimus improved the skin lesions moderately.
The expression levels of CD63, CD69, and CD203c on 
basophils in peripheral blood were evaluated before treatment 
by flow cytometry. Basophils were detected as CD3– CTRH+ 
cells (Fig. 2A). The expression levels of CD63, CD69, and 
CD203c on basophils in case 1 (Fig. 2B) and case 2 (Fig. 2C) 
were upregulated compared with those in healthy donors (n = 4). 
In addition, infiltration of basophils into the lesion 
skin was found in both cases (Fig. 3).
DISCUSSION
The aetiology of papuloerythroderma remains 
largely unknown. It has been suggested to be a 
reaction to an unidentified cutaneous antigen, 
or there may be an association with neoplasia 
or drugs (4). Although peripheral eosinophilia 
and elevated serum IgE were detected in most 
cases of papuloerythroderma, there has been 
no analysis of the role of Th2 immune cells in 
the pathogenesis of papuloerythroderma thus 
far. To the best of our knowledge, this is the 
first demonstration that peripheral basophils 
are activated in patients with papuloerythro-
derma. Basophils release multiple mediators 
(e.g. leukotrienes, proteases, and cytokines, 
such as IL-4) that might be linked directly 
to Th2 skewing in the patient’s papuloery-
throderma. Although the number of cases 
is limited, our results may shed light on the 
possibility that basophils play a role in the 
pathogenesis of papuloerythroderma. 
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Fig. 2. (A) Gating strategy for basophils. (B) Histogram of each maker of basophil in 
patient 1, and patient 2 in comparison with (C) healthy donor (n = 4).
Fig. 3. Basophils were detected using 
anti-human basophils antibody, 2D7 
(purchased from BioLegend, San Diego, 
CA, USA), in patients 1 and 2 (arrows). 
Immunostaining × 400.
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